DMK PHARMACEUTICALS CORPORATION: cashflow_investing

Value{"amount": 3483909, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityDMK PHARMACEUTICALS CORPORATION
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001387131-23-003523 · Open the official SEC filing →
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000887247/cashflow-investing/2022-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/1fb2813e-a755-4da2-a879-e7dcee177047

History

From the Record